Cargando…
BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting
The management of advanced-stage melanoma is clinically challenging, mainly because of its resistance to the currently available therapies. Therefore, it is important to develop alternative therapeutic strategies. The sigma-2 receptor (S2R) is overexpressed in proliferating tumor cells and represent...
Autores principales: | Sorbi, Claudia, Belluti, Silvia, Atene, Claudio Giacinto, Marocchi, Federica, Linciano, Pasquale, Roy, Neena, Paradiso, Elia, Casarini, Livio, Ronsisvalle, Simone, Zanocco-Marani, Tommaso, Brasili, Livio, Lanfrancone, Luisa, Imbriano, Carol, Di Rocco, Giulia, Franchini, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253401/ https://www.ncbi.nlm.nih.gov/pubmed/37298633 http://dx.doi.org/10.3390/ijms24119684 |
Ejemplares similares
-
Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function
por: Belluti, Silvia, et al.
Publicado: (2023) -
Identification of a Potent and Selective 5-HT(1A) Receptor Agonist with In Vitro and In Vivo Antinociceptive Activity
por: Linciano, Pasquale, et al.
Publicado: (2020) -
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group
por: Linciano, Pasquale, et al.
Publicado: (2021) -
In Vitro, Ex Vivo, and In Vivo Models for the Study of Pemphigus
por: Lotti, Roberta, et al.
Publicado: (2022) -
Exhaustive CoMFA and CoMSIA analyses around different chemical entities: a ligand-based study exploring the affinity and selectivity profiles of 5-HT(1A) ligands
por: Guariento, Sara, et al.
Publicado: (2017)